etoposide has been researched along with Hematoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hulsbergen-van de Kaa, CA; Oyen, WJ; Spermon, JR; Strijk, SP; Witjes, JA | 1 |
| Chowhan, N; Davis, R; Hentschel, P; Iliya, A; Madajewicz, S; Manzione, J; Meek, A; Roche, P; Roque, C; Shady, M; Tfayli, A | 1 |
2 other study(ies) available for etoposide and Hematoma
| Article | Year |
|---|---|
Solitary skull recurrence from stage I seminomatous germ cell tumor of testis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Diagnostic Errors; Etoposide; Head and Neck Neoplasms; Hematoma; Humans; Male; Orchiectomy; Radiotherapy, Adjuvant; Remission Induction; Scalp; Seminoma; Skin Neoplasms; Skull Neoplasms; Soft Tissue Neoplasms; Testicular Neoplasms | 2004 |
Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cisplatin; Etoposide; Female; Glioblastoma; Hematoma; Humans; Infusions, Intra-Arterial; Lymphoma; Male; Middle Aged; Nausea; Retrospective Studies; Vomiting | 1999 |